Platelet Transfusions Indications, dose and administration

Slides:



Advertisements
Similar presentations
THE JOINT COMMISSION PATIENT BLOOD MANAGEMENT PERFORMANCE MEASURES
Advertisements

Prepared By: Miss. Sana’a AL-Sulami. Outlines: What is the blood transfusion. Purpose of blood transfusion. Assessment of the patient. Planning for blood.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Leucocyte depleted blood products. BCSH;Transfusion Medicine, 1998,8,59-71 Dr. Tariq Roshan 23 rd March 2003.
Transfusion Management of massive haemorrhage in children Ongoing severe bleeding (overt / covert) and received 20ml/kg of red cells or 40ml/kg of any.
Blood Components Dosage And Their Administration
Hello. Blood Transfusion What is a Blood Transfusion? Blood transfusion is a medical procedure that needs to be ordered by a physician. It is the introduction.
INDICATIONS FOR EMERGENT TRANSFUSIONS Manjushree Matadial DO Saint Joseph Hospital and Medical Center, April 27,2009.
Indications for Platelet Transfusion Laura Cooling MD, MS Associate Medical Director Transfusion Medicine.
National Comparative Audit Platelet Working Group Version 1, Dec 2012 Platelet Transfusion – scope to improve practice Facts and Figures for Healthcare.
Introduction of « TRIMA » in a Regional Blood Transfusion Organisation Dr Bernard LAMY.
An Automobile Accident Victim Up to 50 units of red blood cells An Organ Transplant Recipient Up to 40 units of red blood cells 30 units of platelets 25.
Islam Mohammad Shehata 2010 Department of I.C.U.and Anesthesia.
BLOOD BANKING 1- BLOOD PRODUCTS 2- AUTOLOGOUS TRANSFUSION M. H. Shaheen Maadi Armed Forces Hospital.
Single-Donor Platelets: Arguments for Preferential Use Paul M. Ness, MD Transfusion Medicine Division Johns Hopkins Medical Institutions.
Transfusion Quiz “Their Lives in Your Hands” Doctors.
DDr.Susheela Innah Professor &HoD Dept of Transfusion Medicine Jubilee Mission Medical College, Thrissur.
MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.
1 Massive Blood Transfusion Massive transfusion, defined as the replacement by transfusion of more than 50 percent of a patient's blood volume in 12 to.
4th year medical students Blood Component Therapy Salwa I Hindawi MSc FRCPath CTM Director of Blood Transfusion Services KAUH. Jeddah.
A bleeding diathesis has been recognized in pt. with CCHD, a variety of coagulation abnormalities has been postulated: 1- Polycythemia 2- Hyper viscosity.
THE RATIONAL USE OF BLOOD AND BLOOD PRODUCTS
Senior clinician Request: a o 4 units RBC o 2 units FFP Consider: a o 1 adult therapeutic dose platelets o tranexamic acid in trauma patients Include:
Transfusion of Blood Product History: 1920:Sodium citrate anticoagulant(10 days storage) 1958: Plastic bag of transfusion 1656: Initial theory and.
TRANSFUSION MEDICINE MBBS,MCPS,FCPS. Professor of Pathology
General Approach of Haemostasis
+ Dr. Megan Rowley Consultant in Transfusion Medicine Blood Transfusion.
Why PLANET-2 needs to succeed? Simon Stanworth Anna Curley.
The Clinical Guide “A Guide to Implementing Renal Best Practice in Haemodialysis“ Chapter 5: Anticoagulation Team Leader: Angela Henson Co-authors: Franta.
BLOOD COMPONENT PREPARATION
Blood Component Therapy
The Journey of Blood. Blood- the life source Slide 1: Blood is a scarce and vital national resource which cannot be synthesized. About 80 million unit.
Module 1: The Journey of Blood: Donation to Distribution Transfusion Training Workshop KKM 2012.
Initial Management of Fever or Suspected Infection In Paediatric Oncology and Stem Cell Transplantation Patients Clinical Practice Guideline 1 st edition.
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
Preparation of blood components
1 Vaccines Contraindications. Contraindications to any routine active immunization procedure An acute febrile illness, malaise, cough, diarrhea, or other.
بنام خدا.
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
LPHS Blood Drive May 18, Blood. What is it? There are four main components of blood. Red Blood Cells White Blood Cells Platelets Plasma.
Blood Transfusion Safe Practice.
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics Roles Senior clinician Coordinate team and allocate roles Determine volume and type.
Transfusion Christine Sullivan Transfusion Practitioner.
Types of Apheresis Blood taken from a healthy donor can be separated into its component parts during blood donation, where the needed component is collected.
Miscellaneous Topics in Transfusion
Yadegarynia, D. MD..
Blood Transfusions.
Neonatal Platelet Transfusion Indications
بنام خداوند.
K A U H Blood bank Wesaam Al-Sheyyab.
BLOOD & BLOOD PRODUCTS.
General Approach of Haemostasis
Determination of Hematocrit value (H)
Warfarin Toxicity Treatment & Management
No:18 Red Cell Contamination In Leukapheresis Product-
General Approach in Investigation of Hemostasis
محاسبه حجم خون ازدست رفته در اطفال
Erythrocytapheresis.
HEV negative blood components are indicated in:
Benefits of autotransfusion
Nova Scotia Update NAC Meeting October 15-16, 2015.
Intraoperative Cell Salvage
Ethical Considerations for Pediatric Clinical Investigations
EXTENT OF CHANGES IN PRE AND POSTDONATION DONOR VARIABLES IN SINGLE AND DOUBLE DOSE PLATELETPHERESIS AND ITS IMPLICATIONS ON DONOR SAFETY Dr. R. Sreedevi.
Blood donation Did you know that every day, new medical treatments are being developed and more operations are being carried out? Not surprisingly, blood.
Medication Administration for Pediatrics
GRANULOCYTES ABO compatibility:
Blood Components Dosage And Their Administration
Presentation transcript:

Platelet Transfusions Indications, dose and administration Indications for platelet transfusions Decision to transfuse should be based on both laboratory investigations and assessment of the clinical condition with careful consideration of risks & benefits. Platelet transfusion is not indicated in all cases of thrombocytopenia and may be contraindicated (e.g. immune thrombocytopenia, thrombotic thrombocytopenia and heparin induced thrombocytopenia). Dosing recommendations Platelet dose is generally 5 to 10ml/kg. Usual platelet dose in an adult is 1 adult unit. “Don’t use 2 when 1 will do” Avoid giving excess volume to neonates, infants and small children. Blood bank will supply the most appropriate unit in stock. Platelet Indication Platelet count Oncology Chemotherapy, haemopoetic stem cell transplantation <10 x 10^9/L Chemotherapy, haemopoetic stem cell transplantation & risk factors (e.g. fever, minor bleeding) <20 x 10^9/L Lumbar puncture and new disease induced thrombocytopenia <50 x 10^9/L Lumbar puncture and on-going chemotherapy induced thrombocytopenia <30 x 10^9/L Invasive procedures Patient undergoing invasive procedure Patient undergoing high risk invasive procedure (e.g. neuro surgery) <100 x 10^9/L Critically ill patients - limited evidence, suggested thresholds: Note: higher transfusion triggers may be acceptable in certain circumstances No bleeding No bleeding & risk factors (e.g. sepsis, renal failure, medications) Extra Corporeal Life Support (lower platelet counts may be acceptable in stable patients) Active bleeding Neonatal thrombocytopenia <30-50 x 10^9/L It may be that only a portion of the pack/unit will be administered or multiple pedipaks will be supplied if an adult unit is not available. <10 kg 10-20 kg 20-30 kg 30-40 kg >40 kg Pooled platelets (adult unit) 5ml/kg to 10ml/kg 1 unit or 10ml/kg Which ever is less 1 unit Apheresis platelets (adult unit) Paediatric apheresis platelets (pedipak) 1 pedipak or 5 - 10 ml/kg Which ever is less 2 pedipaks or 5 - 10 ml/kg Which ever is less 3 pedipaks or 5 - 10 ml/kg Which ever is less 4 pedipaks or Weight Platelet product All platelet products are leucocyte depleted and irradiated Stored at room temperature, never in fridge Shelf life 5 days Platelet products, volume and expected platelet increment Product Description Volume Expected platelet increment Pooled platelets (adult unit) Platelets collected from 4 separate donors and pooled into 1 unit >160 ml. Average 326 ml 1 unit typically increases count by 20 - 40 x 10^9/L in 70 kg adult Apheresis platelets (adult unit) Single donor platelets, suspended in donor’s plasma Can be used to decrease donor exposure in patients frequently transfused. 100–400 ml. Average 180 ml Paediatric apheresis platelets (pedipak) Single donor platelets split into 3 to 4 packs (pedipaks) of equal volume Can be used to reduce donor exposure and minimise product wastage 40–60 ml. Average 51 ml 1 pedipak typically increases count in 18kg child by 20 x 10^9/L Platelet administration Use new blood administration filter (170 to 200 micron) when administering platelets. Use a volumetric pump or syringe driver whenever possible Do not transfuse platelets via same blood administration filter after red cell transfusion as some platelets may get caught in fibrin strands/debris caught in filter. (Exception – critical bleeding. Can continue to use same filter unless flow is impeded by debris caught in filter). Suggest administer over 1 to 2 hours. Increased transfusion rates may be associated with increased risk of transfusion reactions. Must be completed within 4 hours.